Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

During the Trading Day
54.36 +0.99 / +1.85%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
54.20 -0.16 / -0.29%
Volume: 1.2K
Health Technology

Company Description

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with huntington's disease, an orphan disease, and tardive dyskinesia and tourette syndrome, subsets of either of which may be deemed to be orphan diseases, as well as other orphan indications. The company uses unique properties of deuterium to develop a pipeline of innovative drugs in several important disease areas. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in La Jolla, CA.

Contact Information

Auspex Pharmaceuticals, Inc.
3366 North Torrey Pines Court
La Jolla California 92037
P:(858) 558-2400
Investor Relations:
(858) 875-5896



Individual stakeholders52.85%
Other institutional23.12%
Mutual fund holders21.99%

Top Executives

Bharat M. ChowriraCOO & Head-Business Development
John P. SchmidChief Financial Officer & Head-Investor Relations
Andreas SommerSecretary & Vice President-Research
David A. StamlerChief Medical Officer
Samuel R. SaksDirector & Chief Development Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.